Subsequent Events (Details Narrative)

3 Months Ended

Mar. 31, 2013

Notes to Financial Statements

Subsequent Events Description

In April 2013, the Company issued one additional promissory note in the principal amounts of $2,000 (the “$2K Note”). As additional consideration for the purchase of the $2K Note, the Company issued 2,000 warrants to purchase shares of FluoroPharma Medical, Inc. (“FPMI”) common stock, for $1.00 per share (“FPMI Warrants”), to the purchasers, The $1.00 FPMI Warrants expire on February 15, 2019.

On April 8, 2013, the Company filed a Summary Judgement in Lieu of Complaint (the "Complaint") against Genomics USA, Inc. ("GUSA") to recover all amounts due the Company under the terms of a promissory note in the principal amount of $200,000 (the "GUSA Note").  The Complaint was filed in the Supreme Court of the State of New York, and seeks repayment of all amounts due under the terms of the GUSA Note, and accrued interest thereon, plus attorney's fees.